| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |